awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q48644058-40E5C9AD-F82C-4DAB-9838-AAA5636CA184
Q48644058-40E5C9AD-F82C-4DAB-9838-AAA5636CA184
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48644058-40E5C9AD-F82C-4DAB-9838-AAA5636CA184
Combination of Imatinib Mesylate and AKT Inhibitor Provides Synergistic Effects in Preclinical Study of Gastrointestinal Stromal Tumor.
P2860
Q48644058-40E5C9AD-F82C-4DAB-9838-AAA5636CA184
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48644058-40E5C9AD-F82C-4DAB-9838-AAA5636CA184
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9480062d1cbcf7fc7331c3e0703e9f9e260d81fb
P2860
microRNA-218 increase the sensitivity of gastrointestinal stromal tumor to imatinib through PI3K/AKT pathway.